British Journal of Dermatology · 1984 · 130 citations · 12 references
Life SciencesDermatologyImmunologyAllergyHypersensitivityInflammationAllergic Skin DiseasesInflammatory DermatosesInflammatory MediatorsInflammatory ProcessesInflammatory SignalingInflammatory Skin DiseasesInflammatory ActivationInflammatory Mediator PharmacologyInflammatory Skin ChangesInflammatory Skin ResponsesLocal Inflammatory Skin ResponsePlatelet-activating Factor SignalingProstaglandin PharmacologyProstaglandin-mediated Inflammation
The phospholipid PAF-acether is released from a range of inflammatory cell types and, in experimental animals, has properties appropriate to a mediator of inflammation. We have studied the inflammatory characteristics of intradermally injected PAF-acether in human skin. An early weal and flare response was succeeded, in a proportion of subjects, by an area of late-onset erythema at the site of the resolved weal, reminiscent of the dual response to allergen in sensitized individuals. The time-course and dose-response relationship of the early response has been determined and a synergistic interaction between PAF-acether and prostaglandin E2 established. PAF-acether should therefore be considered as a potential mediator of both acute and persisting inflammation in man.
12
The Journal of Investigative Dermatology
Naomi M. Kanof · Archives of Dermatology · 1967 · 1.4K citations
The Journal of Allergy and Clinical Immunology
Journal of Allergy and Clinical Immunology · 1999 · 1.1K citations · Full text